(NasdaqGM:ZNTL), Completed enrollment in DENALI Part 2a; dose confirmation expected in 1H 2026 DENALI Part 2 trial topline readout expected by year end 2026; potential to support accelerated approval Initiation of the ASPENOVA Phase 3, randomized, confirmatory trial planned in 1H 2026 SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) — Zentalis(R) Pharmaceuticals, Inc. (Nasdaq: ZNTL), […]

(NASDAQ:HTFL), MOUNTAIN VIEW, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) — Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis is now covered by Aetna across all lines of business, including Commercial, Medicare Advantage, and Aetna Better Health Medicaid plans. Aetna is the fourth major

COLUMBUS, Ohio, Jan. 06, 2026 (GLOBE NEWSWIRE) — This week, the Central Ohio Transit Authority (COTA) launched Tap to Pay, a new way to pay that allows customers to purchase their fare by tapping a credit card, debit card or their digital wallet from a phone or smartwatch. Tap to Pay provides an additional, convenient

(NASDAQ:VOR), BOSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will be presenting and hosting 1×1 investor meetings at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Presentation: Tuesday, January 13, 2026 at 10:30am – 11:10

Las Vegas, Jan. 06, 2026 (GLOBE NEWSWIRE) — Key Highlights Brane Audio debuts RAD2, the most efficient way to create deep bass. RAD2 delivers a 30-fold deep-bass advantage compared to conventional drivers, breaking the long-standing trade-off between deep bass, size, and power draw. RAD2 will make its first commercial appearance in 2026 with the Brane

(NASDAQ:GLTO), Deep hematology/oncology drug development experience added with the appointment of Sherwin Sattarzadeh as Chief Operating Officer and Becker Hewes as Chief Medical Officer DMR-001, a potentially best-in-class mutant calreticulin (“mutCALR”) targeting monoclonal antibody, on track for IND submission in mid-2026 with anticipated first-in-human dosing via subcutaneous administration Cash balance, including $285 million raised in

(TSX:PD),(NYSE:PDS), CALGARY, Alberta, Jan. 06, 2026 (GLOBE NEWSWIRE) — This news release contains “forward-looking information and statements” within the meaning of applicable securities laws. For a full disclosure of the forward-looking information and statements and the risks to which they are subject, see the “Cautionary Statement Regarding Forward-Looking Information and Statements” later in this news

(NYSE:ABM), NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility, engineering, and infrastructure solutions, today announced the promotions of Melanie Kirkwood Ruiz to Executive Vice President and Chief Information Officer and Tom Gallo to Executive Vice President and Chief Strategy Officer. Both leaders will continue to report to

(NASDAQ:SOWG), IRVING, Texas, Jan. 06, 2026 (GLOBE NEWSWIRE) — Sow Good Inc. (NASDAQ: SOWG) (“Sow Good” or the “Company”), a leading freeze-dried food and candy manufacturer, today announced the completion of a series of strategic transactions designed to strengthen its liquidity position, transition the business to a more asset-light operating model, and provide flexibility as

(NASDAQ:SNCR), BRIDGEWATER, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (“Synchronoss”) (NASDAQ: SNCR), a global leader and innovator in personal cloud solutions, today announced expanded capabilities across its white-label Synchronoss Personal Cloud platform at CES 2026 in Las Vegas. The company is also highlighting continued momentum for Capsyl, its turnkey personal cloud solution,